| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/26/1993 | CA2077309A1 Polymeric carriers for release of covalently linked agents |
| 03/25/1993 | CA2078359A1 Protein-dimeric polysaccharide conjugate vaccine |
| 03/24/1993 | EP0533492A2 A hepatitis B vaccine formulation incorporating a bile acid salt |
| 03/24/1993 | EP0533294A1 Chicken anaemia agent vaccine |
| 03/24/1993 | EP0533263A2 A multivalent hepatitis B virus vaccine |
| 03/24/1993 | EP0532979A2 Peptides for the preparation of means for diagnosis and therapy of systemic lupus |
| 03/24/1993 | EP0532833A1 Vaccine for equine rhinopneumonitis |
| 03/24/1993 | EP0532716A1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 03/24/1993 | EP0532525A1 New protein-polycation conjugates. |
| 03/24/1993 | EP0345315B1 Ps2 protein derivative |
| 03/24/1993 | EP0248040B1 Ricin-antibody conjugates |
| 03/24/1993 | EP0180603B1 Rotavirus |
| 03/24/1993 | EP0134799B1 Expression of plasmodium falciparum polypeptides from cloned cdna |
| 03/24/1993 | CN1070227A DNA sequences encoding gelonin polypeptide |
| 03/24/1993 | CA2078801A1 Enzymatically inactive phospholipase d of corynebacterium pseudotuberculosis |
| 03/23/1993 | US5196516 Pseudorabies virus vaccine |
| 03/23/1993 | US5196514 Method of detecting mycoplasma infection in poultry and compositions therefor |
| 03/23/1993 | US5196512 For Plasmodium |
| 03/23/1993 | US5196511 Peptides and antibodies that inhibit integrin-ligand binding |
| 03/23/1993 | US5196338 Recombinant vectors for Haemophilus influenzae peptides and proteins |
| 03/23/1993 | US5196337 Human monoclonal antibody, and its production and use |
| 03/23/1993 | US5196324 Monoclonal antibodies reactive with a human atheroma associated antigen |
| 03/23/1993 | US5196194 Vaccines containing Hepatitis B S-protein |
| 03/23/1993 | US5196193 Antivenoms and methods for making antivenoms |
| 03/23/1993 | CA1314769C Magnetically responsive particles and method of preparation |
| 03/21/1993 | WO1993005811A1 A hepatitis b vaccine formulation incorporating a bile acid salt |
| 03/21/1993 | CA2096650A1 Hepatitis b vaccine formulation incorporating a bile acid salt |
| 03/21/1993 | CA2078358A1 Multivalent hepatitis b virus vaccine |
| 03/18/1993 | WO1993005168A1 Dna sequences encoding gelonin polypeptide |
| 03/18/1993 | WO1993005072A1 Disease associated human autoantibodies specific for human thyroid peroxidase |
| 03/18/1993 | WO1993005066A1 Heat labile toxin of bordetella |
| 03/18/1993 | WO1993005061A1 Cloning and characterization of a cardiac adenylyl cyclase |
| 03/18/1993 | WO1993004700A1 Vα12.1 T-CELL RECEPTOR-SPECIFIC REAGENTS FOR DIAGNOSING AND TREATING RHEUMATOID ARTHRITIS |
| 03/18/1993 | WO1993004699A1 Therapeutic method for iddm |
| 03/18/1993 | WO1993004698A1 Method of enhancing anti-rabies immune responses |
| 03/18/1993 | WO1993004697A1 Multideterminant peptide antigens that stimulate helper t lymphocyte response to hiv in a range of human subjects |
| 03/18/1993 | WO1993004695A1 T cell receptor-based therapy for rheumatoid arthritis |
| 03/18/1993 | WO1993004672A1 Method for enhancing the immune system in a host employing liposome-encapsulated polypeptides |
| 03/18/1993 | WO1992012992A3 Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods |
| 03/18/1993 | DE4130689A1 Dry immunological prepn(s). from colostral milk - contain malto:dextrin as solubiliser and have superior dissolution properties than known preparations |
| 03/18/1993 | CA2116526A1 T cell receptor-based therapy for rheumatoid arthritis |
| 03/18/1993 | CA2116453A1 Disease associated human autoantibodies specific for human thyroid peroxidase |
| 03/18/1993 | CA2116339A1 V.alpha.12.1 t-cell receptor-specific reagents for diagnosing and treating rheumatoid arthritis |
| 03/17/1993 | EP0532167A2 Non-A, Non-B Hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems |
| 03/17/1993 | EP0532090A2 Cellular immunity vaccines from bacterial toxin-antigen conjugates |
| 03/17/1993 | EP0531728A1 HSV gD2 Baculovirus expression system |
| 03/17/1993 | EP0531539A1 Lyophilized monoclonal antibody preparation |
| 03/17/1993 | EP0531472A1 Humanized and chimeric monoclonal antibodies |
| 03/17/1993 | EP0531434A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 03/17/1993 | EP0531407A1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
| 03/17/1993 | EP0321489B1 Molecular cloning and clones of human b lymphotropic virus (hblv) |
| 03/17/1993 | EP0317641B1 Fused protein containing lymphotoxin |
| 03/16/1993 | US5194596 Production of vascular endothelial cell growth factor |
| 03/16/1993 | US5194595 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
| 03/16/1993 | US5194594 Conjugation With Heterobifunctional Reagent, Radionucleotide Label |
| 03/16/1993 | US5194591 Isolation of an immunoglobulin rich fracton from whey |
| 03/16/1993 | US5194587 Malaria-specific DNA sequences, expression products thereof, and the use thereof |
| 03/16/1993 | US5194586 Adult T Cell Leukemia Associated Antigen |
| 03/16/1993 | US5194585 Vasoactive peptides |
| 03/16/1993 | US5194425 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 03/16/1993 | US5194376 Diagnosis and treatment of AIDS |
| 03/16/1993 | US5194256 Purified human cytomegalovirus protein |
| 03/16/1993 | US5194254 Antigen coupled to monoclonal antibody |
| 03/16/1993 | CA2064091C Diagnosis for porcine malignant hyperthermia |
| 03/16/1993 | CA1314503C Detectable molecules, method of preparation and use |
| 03/14/1993 | CA2078087A1 Hsv gd2 baculovirus expression system |
| 03/10/1993 | EP0531080A2 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene protein |
| 03/10/1993 | EP0530447A2 Process for purifying IgG monoclonal antibodies and their use |
| 03/10/1993 | EP0530265A1 Dna encoding human 5-ht 1d? receptors and uses thereof |
| 03/10/1993 | EP0417191B1 Formulation for antibody reagents |
| 03/10/1993 | CA2077277A1 Cellular immunity vaccines from bacterial toxin-antigen conjugates |
| 03/09/1993 | US5192684 Human IgG1 monoclonal antibody specific for the nicotinic acetylcholine receptor and hybridoma producing the antibody |
| 03/09/1993 | US5192540 Haemophilus influenzae type b oxidized polysaccharide-outer membrane protein conjugate vaccine |
| 03/09/1993 | US5192539 Infectious bursal disease virus production in continuous cell lines |
| 03/09/1993 | US5192538 Stable forms of antigenic Taenia ovis polypeptides |
| 03/09/1993 | US5192537 Method of treating renal cell carcinoma using activated mononuclear cells, renal tumor antigen and cimetidine |
| 03/09/1993 | CA1314217C Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals |
| 03/05/1993 | CA2077322A1 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins |
| 03/04/1993 | WO1993004175A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 03/04/1993 | WO1993004174A1 Ryegrass pollen allergen |
| 03/04/1993 | WO1993004173A1 Immunoglobulin variants for specific fc epsilon receptors |
| 03/04/1993 | WO1993004163A1 Strain of chlamydia |
| 03/04/1993 | WO1993004089A1 Hepatitis c assay utilizing recombinant antigens from ns5 region |
| 03/04/1993 | WO1993004085A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof |
| 03/04/1993 | WO1993004084A1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same |
| 03/04/1993 | WO1993003766A1 Multiple antigen peptides for use as hiv vaccines |
| 03/04/1993 | WO1993003765A1 Escherichia coli o-polysaccharide-protein conjugate vaccine |
| 03/04/1993 | WO1993003764A1 Hla-restricted hepatitis b virus ctl epitopes |
| 03/04/1993 | WO1993003763A1 Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection |
| 03/04/1993 | WO1993003762A1 Immunostimulation |
| 03/04/1993 | WO1993003761A1 METHODS AND COMPOSITIONS RELATING TO USEFUL ANTIGENS OF $i(MORAXELLA CATARRHALIS) |
| 03/04/1993 | WO1993003760A1 Sirs vaccine and diagnosis method |
| 03/04/1993 | WO1993003759A1 Papua new guinea human t-lymphotropic virus |
| 03/04/1993 | WO1993003753A1 Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus |
| 03/04/1993 | WO1993003735A1 Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients |
| 03/04/1993 | CA2145382A1 Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy |
| 03/04/1993 | CA2116359A1 Anti-hiv proteins gap 31, dap 30, and dap 32, dna coding therefor and therapeutic uses thereof |
| 03/04/1993 | CA2115925A1 Hepatitis c assay utilizing recombinant antigens from ns5 region |
| 03/04/1993 | CA2115554A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 03/04/1993 | CA2115424A1 Immunostimulation |